The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports


Harrow Comes Out of Allergan Lawsuit Unscathed

Contributed Opinion
  ()
Sector expert Daniel Carlson offers his take on the recent jury decision, calling it "very positive." read more >

Why Did ImmunoGen Plummet 32%?

  ()
This biotechnology company, which focuses on the treatment of cancer, received some feedback from the FDA that upset investors on Wednesday. read more >

FDA Approval of Antibiotic for Bacterial Pneumonia Expected in Late Summer

Research Report
  ()
An update on this biopharma's two lead drug candidate programs was provided in an H.C. Wainwright report. read more >
News Update

Biopharma Releases Preliminary Data from Alcoholic Hepatitis Study

News Update
  ()
The results compare favorably to those of the historical control group. read more >

Trial Milestone Reached; U.K.-Based Biopharma Gets $15 Million

Research Report
  ()
The first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. report. read more >

Price Target Raised on Biopharma Ahead of Leukemia Trial Update

Research Report
  ()
The expected data and their implications were addressed in a ROTH Capital Partners report. read more >

'Pivotal Topline Up Next' for Biotech's Phase 3 Cardiac Clinical Trial

Research Report
  ()
A study update and the next steps to advance the therapeutic were covered in a ROTH Capital Partners report. read more >

Immuno-Oncology Firm to Collaborate on Third Clinical Trial with Genentech

Research Report
  ()
Descriptions of the new study and upcoming data readouts for this California-based firm were provided in an H.C. Wainwright & Co. report. read more >
News Update

Firm's AR E-Commerce Solutions to Be Marketed, Sold to Dispensaries

News Update
  ()
With the signing of a reseller agreement, the tech firm continues to penetrate Canada's burgeoning legal cannabis industry. read more >

'Undervalued' Biopharma Features Robust Pipeline, Future Upside

Research Report
  ()
The case for investing in this company was made in an H.C. Wainwright & Co. report. read more >

California Gold Mining Full Speed Ahead in Hemp

Contributed Opinion
  ()
Peter Epstein of Epstein Research provides an update on a mining exploration company that is diversifying into the hemp market. read more >

Analyst: Biopharma, Now Stronger Than Ever, Is an Ideal Takeout Target

Research Report
  ()
An argument is made in a ROTH Capital Partners report for a potential imminent deal involving this drug maker. read more >

Developer of Cannabinoid-Based Drugs to Resume Cancer Pain Trial

Research Report
  ()
Calling this latest development "excellent news," Paradigm Capital has raised its target price on the company's stock. read more >

Immunotherapeutic Agent Shows Efficacy in Rare Respiratory Disease

Research Report
  ()
Trial results for this therapeutic, and their implications for this biotech, were discussed in an H.C. Wainwright & Co. report. read more >

Biopharma Expects Data Readouts in Psoriasis, NASH in H2/19

Research Report
  ()
Two recently launched clinical trials, and related conference calls, were reviewed in an H.C. Wainwright & Co. report. read more >
News Update

Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies

News Update
  ()
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app. read more >

Best-of-Breed Hemp/CBD Producers

Contributed Opinion
  ()
Fincom Investment Partners surveys the hemp-CBD landscape and discusses two companies it believes are "best of breed." read more >
News Update

Biopharma Hits Milestone in Starting Enrollment for NASH Clinical Trial

News Update
  ()
The company will discuss the trial when it hosts a conference call about this specific disease indication in April. read more >

Biopharma's Early Data Show Immunotherapy's Efficacy in Ovarian Cancer

Research Report
  ()
The "encouraging" data for this drug candidate as a monotherapy is the focus of an H.C. Wainwright & Co. report. read more >

California Gold Entering High-CBD Content Hemp Seed Market in the U.S.

Contributed Opinion
  ()
Peter Epstein of Epstein Research profiles a gold company that plans to grow hemp seed on its land. read more >

Premier Health Group Adding Medical Cannabis Support Tool

  ()
This clinical decision support software integration is the first of its kind, according to the company. read more >

San Diego Biopharma Features 'Strong and Balanced Pipeline'

Research Report
  ()
An H.C. Wainwright & Co. report discussed what sets this company's asset apart from similar products. read more >
News Update

Dosing Begins for California Biopharma's Proof-of-Concept Trial in Plaque Psoriasis

News Update
  ()
This U.S. study follows encouraging results from a Phase 1b trial in the same indication in Australia. read more >
News Update

Biotech Stresses Need to Target Only Toxic Oligomer in Alzheimer's Therapies

News Update
  ()
The company cites the recent discontinuation of other firms' clinical programs as proof. read more >

Now Cashed Up, Biopharma to Advance Cholesterol-Lowering Therapy

Research Report
  ()
A ROTH Capital Partners report reviewed this New Jersey firm's plans for its lead asset. read more >
Showing Results: 1 to 25 of 68 Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe